850839-TOBRA
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
Compare the effect of Vancomycin and Tobramycin powder combined vs. Vancomycin powder to reduce surgical site infections in patients age 18-80 with tibial plateau/pilon fractures at high risk of infection treated operatively with plate and screw fixation. Control will receive 1000 mg Vancomycin powder in wound closure while treatment will receive 1000 mg Vancomycin powder AND 1200 mg Tobramycin powder. Patients will be followed at 2 weeks, 3, 6, and 12 months post fracture fixation surgery.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
07 Aug 2024.
Study ID: 850839
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
